II. Definitions
- Epinephrine (Adrenaline)
- Natural Catecholamine, synthesized and released from the Adrenal Medulla as a stress response (along with Norepinephrine)
- Has both alpha and beta adrenergic activity
III. History
- Medical case report in 1923 on intracardiac Adrenaline
- Shown to reverse "Acute heart paralysis"
IV. Physiology
-
General
- Epinephrine has a short Half-Life: ~2 minutes
- As with other Catecholamines, Epinephrine is rapidly metabolized by COMT and MAO
- Epinephrine has a short Half-Life: ~2 minutes
-
Alpha Adrenergic Agonist Effects
- Most important medication in Cardiac Arrest and Anaphylaxis
- Vasoconstriction (a1)
- Increases Systemic Vascular Resistance
- Increases Systolic and Diastolic Blood Pressure
- Increases Vital Organ Perfusion
- Increases Myocardial perfusion
- Increases Cerebral perfusion
- Decreases Non-Vital Organ Perfusion
- Decreases splanchnic and intestinal perfusion
- Decreases renal perfusion
- Decreases skin perfusion
-
Beta Adrenergic Agonist effects (Under 0.3 mcg/kg/min)
- Cardiac Effects
- Increases myocardial contractility (b1)
- Increases Heart Rate (b1)
- Lung Effects
- Relaxes Bronchial Smooth Muscle or bronchodilation (b2)
- Endocrine Effects
- Increases Serum Glucose via Gluconeogenesis and Glycogenolysis (b2)
- Increases Fatty Acids via fat cell lipolysis of Triglycerides (b1)
- Gastrointestinal and Genitourinary Effects
- Decreased intestinal tone and motility (alpha, b2)
- Urinary sphincter contraction (alpha)
- Uterine contraction outside of pregnancy (a1)
- Uterine relaxation in near-term and peripartum period (b2)
- Cardiac Effects
V. Indications
- Anaphylaxis
- Status Asthmaticus
- Initial Resuscitation Management (bolus)
- Cardiac Arrest (VT/VFib, PEA)
- Vasopressin may be used instead in some protocols
- Symptomatic Bradycardia unresponsive to other measures (oxygenation, ventilation)
- Hypotension refractory to volume replacement (see Vasopressor)
- Cardiac Arrest (VT/VFib, PEA)
- Post-Resuscitation Stabilization (Infusion)
- Significant Bradycardia with hemodynamic instability
- Poor systemic perfusion or Hypotension despite
- Intravascular volume replacement AND Stable rhythm
VI. Dosing: Newborn (refractory and persistant Bradycardia)
- Epinephrine (1:10,000) 0.1 to 0.3 ml/kg by IV or ET
- Do not use the 1:1000 concentration in newborns
VII. Dosing: Pediatric
-
Symptomatic Bradycardia (with a pulse)
- Dose: 0.01 mg/kg IV/IO (0.1 ml/kg of 1:10,000 Epi)
-
Pulseless Cardiac Arrest
- Initial regular dose Epinephrine
- Dose: 0.01 mg/kg IV/IO (0.1 ml/kg of 1:10,000 Epi)
- Subsequent High Dose Epinephrine (if no effect above)
- Dose: 0.1 mg/kg IV/IO (0.1 ml/kg of 1:1000 Epi)
- Maximum dose: 0.2 mg/kg
- Repeat dose every 3-5 minutes
- Initial regular dose Epinephrine
- Endotracheal Administration
- Adults and children: 0.1 mg/kg (0.1 ml/kg of 1:1000)
- Newborn: 0.1 mg/kg (1 ml/kg of 1:10,000)
VIII. Dosing: Pediatric Infusion (Same as Isoproterenol preparation)
- Preparation
- Draw up "x" mg of Epinephrine
- Where "x" = 0.6 x WeightKg
- Add enough D5W or NS to Epinephrine for 100 ml total
- At this dilution
- Infusion rate of 1 ml/h provides 0.1 ug/kg/h
- Start Dose: 20 ml/hour until Tachycardia
- Indicates drug has entered circulation
- Titrate Dose
- Decrease to desired rate (0.1 - 1.0 ug/kg/min)
- Adjust infusion rate every 5 min to desired effect
IX. Dosing: Adult Pulseless Arrest
- Rhythms
- Initial
- IV: 1 mg (10 ml of 1:10,000 Epi) IV push
- Endotracheal: 2.5 ml of 1:1000 Epi in 10 ml NS
- Repeat every 3-5 minutes
- Consider increasing dose to 3 or 5 mg (0.1 mg/kg)
X. Dosing: Anaphylaxis "Dirty" Epinephrine drip ("dirty epi drip")
- Indicated if repeat intramuscular Epinephrine dosing is required for Anaphylaxis
- Ordered at the time of second IM Epinephrine dose
- Preparation: Epinephrine 1 mcg/ml solution
- Draw up 1 mg of Epinephrine (1 ml of 1:1000 or 10 ml of 1:10000)
- Inject 1 mg Epinephrine into 1 Liter bag of Normal Saline (now 1 mcg/ml Epinephrine)
- Given 1 cc/20 drops AND 1 mcg/ml Epinephrine
- Goal rate: 6 mcg/min
- Equates to 2 drops per second
- Infusion: Epinephrine 1 mcg/ml solution
- Protocol 1: Hypotensive, Unstable Patient option 1
- Draw into syringe, 10 ml (10 mcg) from 1 mcg/ml Epinephrine solution prepared above
- Inject 5 ml (5 mcg) IV (may repeat second 5 ml/5 mcg dose)
- Protocol 2: Hypotensive, Unstable Patient option 2
- Open Epinephrine solution IV (flows at 20-50 mcg/min through 18 gauge IV)
- Provider stands by the bedside and closely controls infusion
- Titrate until patient hemodynamically stable
- Decrease the Epinephrine flow as patient becomes hemodynamically stable
- Decrease flow towards 1-4 mcg/min
- Wean as approach cummulative max IV Epinephrine dose
- Max cummulative dose: 100 mcg (3-5 min with open IV)
- Equivalent of the initial Anaphylaxis guideline
- Recommended bolus of 0.1 mg IV push over 5 minutes
- Wean as approach cummulative max IV Epinephrine dose
- Protocol 3: Cautious titration
- Start infusion at 1 mcg/min and titrate to effect (typically 1-4 mcg/min)
- Protocol 1: Hypotensive, Unstable Patient option 1
- References
- Lin in Herbert (2014) EM Rap 14(1): 7
XI. Dosing: Adult Infusion for Symptomatic Bradycardia
- Preparation
- Draw up 1 mg Epinephrine (1 ml of 1:1000)
- Add Epinephrine to 500 ml Normal Saline or D5W
- Start Dose: 1 ug/min
- Titrate Dose to desired effect (2-10 ug/min)
XII. Dosing: Adult Push Dose Pressor for Hypotension refractory to fluid bolus
- See Push Dose Pressor
- See Intravenous Phenylephrine
- Precautions
- Limit Push Dose Pressors to emergency use
- Mixing errors are common (Exercise caution)
- When adequate time is available, pharmacy prepared solutions are preferred
- Push Dose Pressors are a temporizing measure to stabilize Hypotension
- In some cases, Push Dose Pressor alone may be sufficient (e.g. Propofol induced Hypotension)
- Prepare for Vasopressor infusion (e.g. Norepinephrine, Epinephrine) if expected persistent Hypotension
- Preparation
- Start with 9 ml of Normal Saline in 10 ml syringe
- Draw 1 ml of Cardiac Epinephrine (100 mcg/ml or 0.1 mg/ml or 1 to 10:000 dilution) in vial
- Final Concentration: Epinephrine 10 mcg/ml
- Dose
- Epinephrine (10 mcg/ml) 0.5 to 2 ml (5-20 mcg) every 2-5 minutes
- Expect onset of action within 1 minute and effect lasting 5-10 minutes
XIII. Precautions
- Carefully check concentration (1:1000 OR 1:10,000)
- Observe for side effects after Resuscitation
- Extravasation into tissues
- may causes local ischemia or necrosis
- Can exacerbate Myocardial Ischemia
- Do not mix with alkaline solutions
XIV. Efficacy: Cardiac Arrest
- See Guidelines for Emergency Cardiovascular Care
- Epinephrine is recommended in most of the ACLS cardiac guidelines 2010 (recommendation 2B)
- More recent data since 2010 guidelines may lead to future modified recommendations (research topic only for now)
- Epinephrine appears to have no effect on neurologically intact survival despite significantly increasing rate of ROSC
- Early use of Epinephrine in Cardiac Arrest may be associated with better outcomes
- Epinephrine has theoretical risks in Cardiac Arrest
- Tachydysrhthythmias
- Increased myocardial oxygen demand
- Thrombogenesis
- References
- Swaminathan and Hayes in Herbert (2014) EM:Rap 14(6): 7-8
XV. References
- Olson (2020) Clinical Pharmacology, Medmasters, Miami, p. 13-33
- Goldstein (2010) Clin Auton Res 20(6):331-52 +PMID: 20623313 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
epinephrine (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
EPINEPHRINE 0.15 MG AUTO-INJCT | Generic | $127.35 each |
EPINEPHRINE 0.3 MG AUTO-INJECT | Generic | $137.05 each |